Learn about North Carolina Med Care Commn Hospital Revenue Investor Relations including Events and Key Fiscal Officers.
About North Carolina Med Care Commn Hospital Revenue
Welcome to the investor relations page for North Carolina Med Care Commn Hospital Revenue. Here you'll find comprehensive financial information about our organization's fiscal health, including bond offerings, official statements, ratings, and continuing disclosure filings sourced from MSRB EMMA.
We appreciate your interest in our bond programs and invite you to explore the financial data and documents available on this site.
Contact Information
| Website | https://northcarolina.gov |
Get an overview of our bonds and ratings.
Bond Sales
There are currently no bond sales listed. Add this issuer to your watchlist to get alerts about important updates.
Securities (CUSIPs)
Browse documents from North Carolina Med Care Commn Hospital Revenue Investor Relations by category.
Document Categories
No documents available yet
Add this issuer to your watchlist to get alerts when new documents are posted.
+ Add to WatchlistView additional resources from North Carolina Med Care Commn Hospital Revenue Investor Relations, including our MSRB EMMA® Links, Frequently Asked Questions, Contact Information, Links to NC Agencies and Additional Resources.
MSRB EMMA® Links
View a list of our CUSIPs and see links to more information about our municipal bonds on the MSRB EMMA® website.
CUSIP6: 65820H
Frequently Asked Questions
Looking for more information about us and our bond programs? Get answers to common questions by following the link below.
Contact North Carolina Med Care Commn Hospital Revenue
Still have questions? You can reach us by mail, phone, or email.
Links to NC Agencies and Additional Resources
NC Agencies
North Carolina Med Care Commn Hospital Revenue: View the official website for North Carolina Med Care Commn Hospital Revenue.
Issuer Details
| State | NC |
| Issuer Type | Other Revenue |
| CUSIP6 | 65820H |
| Total Outstanding Par | $2,500,565,000 |
| Bond Issues | 0 |
| Securities | 85 |
| Transparency | No Filings |